- Home
- NMRA vs NREF Comparison
NMRA vs NREF Comparison
Compare NMRA & NREF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NMRA | NREF |
|---|---|---|
| Founded | 2019 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 302.0M | 296.5M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | NMRA | NREF |
|---|---|---|
| Price | $0.74 | $16.40 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 8 | 2 |
| Target Price | $7.50 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 932.8K | 52.0K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 13.95% |
| EPS Growth | ★ 5.23 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.47 |
| P/E Ratio | ★ N/A | $4.78 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.73 | $12.36 |
| 52 Week High | $3.65 | $18.43 |
Technical Indicators
Market Signals| Indicator | NMRA | NREF |
|---|---|---|
| Relative Strength Index (RSI) | 16.66 | 39.83 |
| Support Level | N/A | $14.45 |
| Resistance Level | $1.74 | $18.15 |
| Average True Range (ATR) | 0.09 | 0.44 |
| MACD | -0.06 | -0.16 |
| Stochastic Oscillator | 0.11 | 24.19 |
Price Performance
Historical ComparisonAbout NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About NREF NexPoint Real Estate Finance Inc.
NexPoint Real Estate Finance Inc is a commercial mortgage REIT focused on generating attractive, risk-adjusted returns for shareholders over the long term. The company invests mainly in first-lien mortgage loans, mezzanine loans, preferred equity, multifamily properties, and common equity investments, as well as multifamily and single-family rental CMBS securitizations, promissory notes, revolving credit facilities, and stock warrants. It focuses on real estate sectors where its management has operating expertise, including multifamily, single-family rental, self-storage, industrial, and life sciences, mainly in top metropolitan areas.